Sort

Search

15/07/2025 Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity
Moscoso, A, Heeman, F, Raghavan, S, Costoya-Sanchez, A, van Essen, M, Mainta, I, Camacho, V, Rodriguez-Fonseca, O, Silva-Rodriguez, J, Perissinotti, A, Gu, YN, Yun, JH, Peretti, D, Ribaldi, F, Coomans, EM, Brum, WS, Grothe, MJ, Aguiar, P, Bischof, GN, Drzezga, A, Seo, SW, Villeneuve, S, Malpetti, M, O'Brien, JT, Rowe, JB, van de Giessen, EM, Ossenkoppele, R, Jagust, WJ, Smith, R, Hansson, O, Frisoni, GB, Garibotto, V, Soleimani-Meigooni, DN, Carrillo, M, Dickerson, BC, La Joie, R, Rabinovici, GD, Apostolova, LG, Lamontagne, PJ, Pontecorvo, MJ, Johnson, KA, Sperling, RA, Weiner, MW, Petersen, RC, Jack, CR, Vemuri, P, Schoell, M. Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2025; 334(3)DOI:10.1001/jama.2025.7817. PMID:40522652. IF:55.000(Q1/1D).
15/07/2025 Durvalumab Alone or Combined With Novel Agents for Unresectable Stage III Non-Small Cell Lung Cancer Update From the COAST Randomized Clinical Trial
Aggarwal, C, Martinez-Marti, A, Majem, M, Barlesi, F, Carcereny, E, Chu, Q, Monnet, I, Sánchez-Hernández, A, Dakhil, S, Camidge, DR, Pillet, M, Brown, M, Paliompeis, C, Dowson, A, Cooper, ZA, Kumar, R, Herbst, RS. Durvalumab Alone or Combined With Novel Agents for Unresectable Stage III Non-Small Cell Lung Cancer Update From the COAST Randomized Clinical Trial. JAMA Network Open. 2025; 8(7)DOI:10.1001/jamanetworkopen.2025.18440. PMID:40663352. IF:9.700(Q1/1D).
13/07/2025 Digital biomechanical assessment of gait in patients with peripheral neuropathies
Tejada-Illa, C, Pegueroles, J, Claramunt-Molet, M, Pi-Cervera, A, Heras-Delgado, A, Gascón-Fontal, J, Idelsohn-Zielonka, S, Rico, M, Vidal, N, Martin-Aguilar, L, Caballero-Avila, M, Lleixà, C, Collet-Vidiella, R, Llansó, L, Carbayo, A, Vesperinas, A, Querol, L, Pascual-Goñi, E. Digital biomechanical assessment of gait in patients with peripheral neuropathies. Journal of NeuroEngineering and Rehabilitation. 2025; 22(1)DOI:10.1186/s12984-025-01694-w. PMID:40653470. IF:5.200(Q1/1D).
11/07/2025 Tight and early HbA1c control in patients with type 2 diabetes mellitus in Spain: quantifying the social value
Merino, M, Maravilla-Herrera, P, Artola, S, Escalada, J, Pérez, A, Remón, J, Trillo-Mata, JL, Vallès-Callol, JA, Hidalgo-Vega, A. Tight and early HbA1c control in patients with type 2 diabetes mellitus in Spain: quantifying the social value. Frontiers in Public Health. 2025; 13DOI:10.3389/fpubh.2025.1511108. PMID:40717941. IF:3.400(Q1/2D).
11/07/2025 YAP1::KMT2A-Rearranged Sarcoma: Report of a New Case With Unusual Morphology and Immunohistochemical Features
Fumagalli, C, Orellana, R, Bagué, S, Ferré, M, Gonzalez, A, Catasus, L, Llauger, J, Peiró, A, Alarcón, PZ, Majercakova, K, Terés, R, Karanian-Philippe, M, Tirode, F, Antonescu, CR. YAP1::KMT2A-Rearranged Sarcoma: Report of a New Case With Unusual Morphology and Immunohistochemical Features. GENES CHROMOSOMES & CANCER. 2025; 64(7)DOI:10.1002/gcc.70059. PMID:40879254. IF:2.800(Q2/5D).
08/07/2025 Lipodystrophy in HIV: Evolving Challenges and Unresolved Questions
Giralt, M, Domingo, P, Quesada-López, T, Cereijo, R, Villarroya, F. Lipodystrophy in HIV: Evolving Challenges and Unresolved Questions. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(14)DOI:10.3390/ijms26146546. PMID:40724797. IF:4.900(Q1/3D).